Showing results (841-850 of 1,190) with videos related to
Sort By:
Pageof 119
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 19, 2024
Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALLHagop Kantarjian, Nicholas J Short, Fadi G Haddad, et al.Clinical Lymphoma, Myeloma & Leukemia|December 17, 2013
Tyrosine kinase inhibitors as initial therapy for patients with chronic myeloid leukemia in accelerated phaseMaro Ohanian, Hagop M Kantarjian, Alfonso Quintas-Cardama, et al.Cancer|February 28, 2019
Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemiaChristopher B Benton, Prajwal C Boddu, Courtney D DiNardo, et al.British Journal of Haematology|June 17, 2025
Efficacy and safety of oral decitabine/cedazuridine in the chronic myelomonocytic leukaemia subpopulations from phase 2 and 3 studiesMichael R Savona, Olatoyosi Odenike, Gail J Roboz, et al.Blood Advances|February 15, 2019
Pracinostat plus azacitidine in older patients with newly diagnosed acute myeloid leukemia: results of a phase 2 studyGuillermo Garcia-Manero, Yasmin Abaza, Koichi Takahashi, et al.Cancer|April 4, 2003
Phase II study of SU5416--a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitor--in patients with refractory myeloproliferative diseasesFrancis J Giles, Maureen A Cooper, Lewis Silverman, et al.British Journal of Haematology|May 12, 2010
A phase I study of vorinostat in combination with idarubicin in relapsed or refractory leukaemiaTapan M Kadia, Hui Yang, Alessandra Ferrajoli, et al.Journal of Neurology|August 18, 2018
Does normal substantia nigra echogenicity make a difference in Parkinson's disease diagnosis? A real clinical practice follow-up studyAraceli Alonso-Canovas, Jose Luis Lopez-Sendon Moreno, Javier Buisan, et al.Journal of Hematology & Oncology|November 16, 2024
Outcomes of patients with acute myeloid leukemia and bone marrow fibrosisSamuel Urrutia, Hagop M Kantarjian, Farhad Ravandi-Kashani, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2010
Phase I/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemiaFarhad Ravandi, Jorge E Cortes, Daniel Jones, et al.Pageof 119